Volitionrx (VNRX) Other Working Capital Changes (2011 - 2025)
Volitionrx (VNRX) posted Other Working Capital Changes of -$78586.0 for Q4 2025, down 28.32% on a QoQ basis from -$61243.0 in Q3 2025, and up 4.68% year-over-year from -$75071.3 in Q4 2024.
Volitionrx (VNRX) Other Working Capital Changes (2011 - 2025) Analysis & Trends
Volitionrx's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$78586.0 for Q4 2025.
- Quarterly Other Working Capital Changes rose 4.68% year-over-year to -$78586.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$262018.0 (down 1.87% YoY) and the FY2025 annual result came in at -$262018.0, down 1.87% from the prior year.
- Other Working Capital Changes was -$78586.0 for Q4 2025 at Volitionrx, down from -$61243.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $13.0 million in Q4 2023 and bottomed at -$10.3 million in Q3 2022.
- A 5-year average of $1.3 million and a median of $6256.0 in 2021 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes gained 16.27% — and 2025, when it retreated 22.92%.
- Volitionrx's Other Working Capital Changes stood at -$49135.0 in 2021, then slipped by 19.8% to -$58865.0 in 2022, then declined by 14.27% to -$67267.0 in 2023, then declined by 22.57% to -$82446.0 in 2024, then gained by 4.68% to -$78586.0 in 2025.
- Business Quant data shows VNRX's Other Working Capital Changes at -$78586.0 in Q4 2025, -$61243.0 in Q3 2025, and -$66129.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -171,106.00 |
| Dec 31, 2025 | -171,106.00 |
| Dec 31, 2025 | -171,106.00 |
| Sep 30, 2025 | 127,929.00 |
| Sep 30, 2025 | 127,929.00 |
| Sep 30, 2025 | 127,929.00 |
| Jun 30, 2025 | -20,183.00 |
| Jun 30, 2025 | -20,183.00 |
| Jun 30, 2025 | -20,183.00 |
| Mar 31, 2025 | -87,376.00 |
| Mar 31, 2025 | -87,376.00 |
| Mar 31, 2025 | -87,376.00 |
| Sep 30, 2024 | -97,402.00 |
| Sep 30, 2024 | -97,402.00 |
| Sep 30, 2024 | -97,402.00 |
| Jun 30, 2024 | -119,176.00 |
| Jun 30, 2024 | -119,176.00 |
| Jun 30, 2024 | -119,176.00 |
| Mar 31, 2024 | 109,978.00 |
| Mar 31, 2024 | 109,978.00 |